BSX

SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery - 10/14 - 11:30 AM ET

BRIEF-Boston Scientific says has access to about $3 bln of cash - 10/14 - 07:40 AM ET

BOSTON SCIENTIFIC CORP SAYS CURRENTLY HAS ACCESS TO APPROXIMATELY $3B CASH - 10/14 - 07:33 AM ET

Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet - 10/14 - 07:30 AM ET

BRIEF-Boston Scientific gives Q3 market share view for drug-eluting stents - 10/14 - 07:16 AM ET

BOSTON SCIENTIFIC Q3 U.S. MARKET SHARE FOR TWO DRUG-ELUTING STENTS ABOUT 45 PCT - 10/14 - 07:04 AM ET

Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter - 10/14 - 07:00 AM ET

XplosiveStocks.com: Boston Scientific Corporation (NYSE: BSX) Xplosive Stock on the Move! - 10/14 - 03:55 AM ET

UPDATE 1-Boston Scientific says most stock sales are over - 10/13 - 10:29 AM ET

FDA Approves Boston Scientific's Next Generation Version Of Taxus Drug-Coated Stent - 10/13 - 09:52 AM ET

BRIEF-BSX on involuntary stock sale by co-founders - 10/13 - 08:38 AM ET

Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders - 10/13 - 08:30 AM ET

Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent - 10/12 - 12:01 PM ET

Boston Sci approved to sell its new heart stent: The FDA move clears the way for the U.S. launch of the medical device maker's Taxus Libert?. - 10/11 - 10:34 PM ET

Boston Scientific (BSX) NewsBite - Trading With Unusual Volume - 10/10 - 03:30 PM ET

UPDATE 1-FDA approves new Boston Scientific stent - 10/10 - 02:05 PM ET

BRIEF-Boston Scientific announces FDA approval of Taxus Liberte stent - 10/10 - 11:18 AM ET

Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent - 10/10 - 11:12 AM ET

Boston Scientific completes enrollment for Taxus Element stent trial - 10/10 - 09:52 AM ET

Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 - 10/10 - 08:30 AM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index